Mayo Clinic
The startup, which recently raised $24 million, said that its one-way encryption is particularly well suited for preserving the integrity of genomic sequences.
Mayo Clinic, Personalis Ink Comprehensive Genomics Research Collaboration
Investigators intend to offer Personalis' comprehensive genomics testing to consenting patients for both clinical use and to aggregate data for ongoing research.
Phenomix, Mayo Clinic Ink Licensing Deal for Obesity Phenotype Blood Test
Phenomix said its MyPhenome test uses a multiomics and artificial intelligence platform to predict patients' obesity phenotypes.
WuXi Diagnostics Closes $150M Series B Financing Round
The Chinese company said it would use some of the funding to advance its integrated diagnostics research and development pipeline.
BRCA2 Variants of Unknown Significance Reclassified Through Functional Data Additions
Researchers reclassified 86 percent of variants initially determined to be VUS, potentially changing surveillance or treatment approaches for patients.
Feb 12, 2020
Jan 29, 2020
Jan 9, 2020